维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="BURNETT J C JR"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Potential future therapies: natriuretic peptides 显示文摘	BURNETT J C Jr	1999	Coron Artery Dis1999，10，9：	1
2	Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? 显示文摘	BURNETT J C Jr RORLEAU J L	2001	Circulation2001，104，15：	1
3	Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure显示文摘	SHAPIRO B P CHEN H H BURNETT J C Jr	2003	Mayo Clin Proc2003，78，：	1
4	Ra- tionale and design of a randomized,double-blind,placebo- controlled clinical trial to evaluate the efficacy of B-type natri- uretic peptide for the preservation of left ventricular function after anterior myocardial infarction显示文摘	Sangaralingham SJ Burnett J C Jr McKie P M	2013	J Card Fail2013，19，8：	1
5	Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure显示文摘	Shapiro B P Chen H H Burnett J C Jr	2003	Mayo Clin Proc2003，78，4：	1
6	Visualizing the basis for paracrine natriuretic peptide signaling in humanheart显示文摘	MARGULIES K B BURNETT J C Jr	2006	CircRes2006，99，：	1
7	Effects of oral tolvaptan in patients hospitalized for worse- ning heart failure: the EVEREST Outcome Trial显示文摘	Konstam M A Gheorghiade M Burnett J C Jr	2007	JAMA2007，297，12：	1
8	Natriuretic peptides in the diagnosis and management of chronic heart failure显示文摘	BOERRIGTER G COSTELLO-BOERRIGTER L C BURNETT JR J C	2009	Heart Fail Clin2009，5，：	1
9	Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population显示文摘	Luchner A Burnett J C Jr Jougasaki M	2000	Journal of Hypertention2000，18，：	1
10	Short-term clinical effects of tolvaptan,an oral vasopressin antagonist,in patients hospitalized for heart failure:the EVEREST clinical status trials显示文摘	GHEORGHIADE M KONSTAM M A BURNETT J C Jr	2007	JAMA2007，297，12：	1
11	Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial显示文摘	Konstam M A Gheorghiade M Burnett J C Jr	2007	JAMA2007，297，12：	1
12	The natriuretic peptides in heart failure:diagnostic and therapeutic potentials显示文摘	Burnett J C Jr	1999	Proc Assoc Am Physicians1999，111，5：	1
13	Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials显示文摘	Gheorghiade M Konstam M A Burnett J C Jr Grinfeld L Maggioni A P Swedberg K	2007	JAMA2007，297，：	1
14	Cardiorenal actions of TRV120027, a novel β-arrestin-biased ligand at the angiotensin Ⅱ type 1 receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure显示文摘	Boerrigter G Lark M W Whalen E J Soergel D G Violin J D Burnett J C Jr	2011	Circ Heart Fail2011，4，：	1
15	Burden of systolic and diastolic ventricular dysfunction in the community:appreciating the scope of the heart failure epidemic显示文摘	Redfield M M Jacobsen S J Burnett J C Jr	2003	JAMA2003，289，2：	1
16	Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage显示文摘	WIJDICKS E F SCHIEVINK W I BURNETT J C JR	1997	J Neurosurg1997，87，2：	1
17	Ventricular structure and function in aged dogs with renal hypertension:A model of experimental diastolic heart failure显示文摘	MUNAGALA V K HART C Y BURNETT J C JR	2005	Circulation2005，111，：	1
18	Cardiorenal syndrome in de- compensated heart failure : prognostic and therapeutic impli- cations 显示文摘	Boerrigter G Burnett J C Jr	2004	Curr Heart Fail Rep2004，1，：	1
19	A new role for the natriuretic peptides:metabolic regulators of the adipocyte显示文摘	Costello Boerrigter L C Burnett J C Jr	2009	J Am Coll Cardiol2009，53，22：	1
20	Lowerrather than higher levels of B - type natriuretic peptides (NT - pro -BNP and BNP) predict short - term mortality in severe heart failurepatients treated with nesiritide显示文摘	MILLER W L BURNETT J C Jr HARTMAN KA	2005	Am J Cardiol2005，96，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示